nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGB3—mammary gland—breast cancer	0.0287	0.179	CbGeAlD
Tirofiban—ITGB3—epithelium—breast cancer	0.016	0.0999	CbGeAlD
Tirofiban—ITGB3—skin of body—breast cancer	0.0152	0.095	CbGeAlD
Tirofiban—ITGA2B—adipose tissue—breast cancer	0.0148	0.0924	CbGeAlD
Tirofiban—ITGB3—adipose tissue—breast cancer	0.0129	0.0807	CbGeAlD
Tirofiban—ITGA2B—bone marrow—breast cancer	0.0128	0.0801	CbGeAlD
Tirofiban—ITGB3—female reproductive system—breast cancer	0.0119	0.0742	CbGeAlD
Tirofiban—ITGB3—adrenal gland—breast cancer	0.0116	0.0724	CbGeAlD
Tirofiban—ITGB3—bone marrow—breast cancer	0.0112	0.0701	CbGeAlD
Tirofiban—ITGB3—endocrine gland—breast cancer	0.0101	0.0628	CbGeAlD
Tirofiban—ITGA2B—lymph node—breast cancer	0.00796	0.0497	CbGeAlD
Tirofiban—ITGB3—lymph node—breast cancer	0.00695	0.0434	CbGeAlD
Tirofiban—Nausea—Fulvestrant—breast cancer	0.000833	0.0027	CcSEcCtD
Tirofiban—Nausea—Toremifene—breast cancer	0.000822	0.00267	CcSEcCtD
Tirofiban—Urticaria—Idarubicin—breast cancer	0.000816	0.00265	CcSEcCtD
Tirofiban—Thrombocytopenia—Chlorambucil—breast cancer	0.000815	0.00264	CcSEcCtD
Tirofiban—Body temperature increased—Raloxifene—breast cancer	0.000812	0.00263	CcSEcCtD
Tirofiban—Body temperature increased—Idarubicin—breast cancer	0.000812	0.00263	CcSEcCtD
Tirofiban—Swelling—Capecitabine—breast cancer	0.000807	0.00262	CcSEcCtD
Tirofiban—Hypertension—Vinblastine—breast cancer	0.000807	0.00262	CcSEcCtD
Tirofiban—Dizziness—Exemestane—breast cancer	0.000806	0.00261	CcSEcCtD
Tirofiban—Myocardial infarction—Irinotecan—breast cancer	0.000803	0.0026	CcSEcCtD
Tirofiban—Myocardial infarction—Mitoxantrone—breast cancer	0.000803	0.0026	CcSEcCtD
Tirofiban—Hypersensitivity—Anastrozole—breast cancer	0.000797	0.00259	CcSEcCtD
Tirofiban—Sweating—Irinotecan—breast cancer	0.000785	0.00255	CcSEcCtD
Tirofiban—Sweating—Mitoxantrone—breast cancer	0.000785	0.00255	CcSEcCtD
Tirofiban—Hypertension—Tamoxifen—breast cancer	0.000784	0.00254	CcSEcCtD
Tirofiban—Myocardial infarction—Gemcitabine—breast cancer	0.000782	0.00254	CcSEcCtD
Tirofiban—Haematuria—Mitoxantrone—breast cancer	0.000781	0.00253	CcSEcCtD
Tirofiban—Myocardial infarction—Fluorouracil—breast cancer	0.000769	0.00249	CcSEcCtD
Tirofiban—Sweating—Gemcitabine—breast cancer	0.000765	0.00248	CcSEcCtD
Tirofiban—Chills—Thiotepa—breast cancer	0.000764	0.00248	CcSEcCtD
Tirofiban—Headache—Exemestane—breast cancer	0.000763	0.00247	CcSEcCtD
Tirofiban—Haematuria—Gemcitabine—breast cancer	0.000761	0.00247	CcSEcCtD
Tirofiban—Dizziness—Ixabepilone—breast cancer	0.00076	0.00246	CcSEcCtD
Tirofiban—Hypersensitivity—Idarubicin—breast cancer	0.000757	0.00245	CcSEcCtD
Tirofiban—Bradycardia—Irinotecan—breast cancer	0.000749	0.00243	CcSEcCtD
Tirofiban—Bradycardia—Mitoxantrone—breast cancer	0.000749	0.00243	CcSEcCtD
Tirofiban—Hypertension—Goserelin—breast cancer	0.000748	0.00243	CcSEcCtD
Tirofiban—Thrombocytopenia—Vinblastine—breast cancer	0.000746	0.00242	CcSEcCtD
Tirofiban—Oedema—Tamoxifen—breast cancer	0.000741	0.0024	CcSEcCtD
Tirofiban—Haemoglobin—Irinotecan—breast cancer	0.000739	0.0024	CcSEcCtD
Tirofiban—Haemoglobin—Mitoxantrone—breast cancer	0.000739	0.0024	CcSEcCtD
Tirofiban—Haemorrhage—Mitoxantrone—breast cancer	0.000735	0.00239	CcSEcCtD
Tirofiban—Haemorrhage—Irinotecan—breast cancer	0.000735	0.00239	CcSEcCtD
Tirofiban—Anaphylactic shock—Melphalan—breast cancer	0.000725	0.00235	CcSEcCtD
Tirofiban—Oedema—Melphalan—breast cancer	0.000725	0.00235	CcSEcCtD
Tirofiban—Thrombocytopenia—Tamoxifen—breast cancer	0.000725	0.00235	CcSEcCtD
Tirofiban—Nausea—Exemestane—breast cancer	0.000724	0.00235	CcSEcCtD
Tirofiban—Haemoglobin—Gemcitabine—breast cancer	0.00072	0.00234	CcSEcCtD
Tirofiban—Headache—Ixabepilone—breast cancer	0.00072	0.00234	CcSEcCtD
Tirofiban—Haemorrhage—Gemcitabine—breast cancer	0.000716	0.00232	CcSEcCtD
Tirofiban—Hyperhidrosis—Tamoxifen—breast cancer	0.000716	0.00232	CcSEcCtD
Tirofiban—Dizziness—Letrozole—breast cancer	0.000716	0.00232	CcSEcCtD
Tirofiban—Dizziness—Anastrozole—breast cancer	0.000716	0.00232	CcSEcCtD
Tirofiban—Pain—Chlorambucil—breast cancer	0.000711	0.00231	CcSEcCtD
Tirofiban—Thrombocytopenia—Melphalan—breast cancer	0.00071	0.0023	CcSEcCtD
Tirofiban—Haemoglobin—Fluorouracil—breast cancer	0.000708	0.0023	CcSEcCtD
Tirofiban—Anaphylactic shock—Goserelin—breast cancer	0.000707	0.00229	CcSEcCtD
Tirofiban—Oedema—Goserelin—breast cancer	0.000707	0.00229	CcSEcCtD
Tirofiban—Haemorrhage—Fluorouracil—breast cancer	0.000704	0.00228	CcSEcCtD
Tirofiban—Thrombocytopenia—Goserelin—breast cancer	0.000693	0.00225	CcSEcCtD
Tirofiban—Hyperhidrosis—Goserelin—breast cancer	0.000684	0.00222	CcSEcCtD
Tirofiban—Nausea—Ixabepilone—breast cancer	0.000683	0.00221	CcSEcCtD
Tirofiban—Dizziness—Raloxifene—breast cancer	0.000679	0.0022	CcSEcCtD
Tirofiban—Headache—Anastrozole—breast cancer	0.000678	0.0022	CcSEcCtD
Tirofiban—Headache—Letrozole—breast cancer	0.000678	0.0022	CcSEcCtD
Tirofiban—Hypertension—Vinorelbine—breast cancer	0.00067	0.00217	CcSEcCtD
Tirofiban—Urticaria—Chlorambucil—breast cancer	0.000661	0.00214	CcSEcCtD
Tirofiban—Chills—Mitoxantrone—breast cancer	0.00066	0.00214	CcSEcCtD
Tirofiban—Chills—Irinotecan—breast cancer	0.00066	0.00214	CcSEcCtD
Tirofiban—Body temperature increased—Chlorambucil—breast cancer	0.000658	0.00213	CcSEcCtD
Tirofiban—Myocardial infarction—Paclitaxel—breast cancer	0.000655	0.00212	CcSEcCtD
Tirofiban—Pain—Vinblastine—breast cancer	0.000652	0.00211	CcSEcCtD
Tirofiban—Headache—Raloxifene—breast cancer	0.000644	0.00209	CcSEcCtD
Tirofiban—Headache—Idarubicin—breast cancer	0.000644	0.00209	CcSEcCtD
Tirofiban—Nausea—Letrozole—breast cancer	0.000643	0.00208	CcSEcCtD
Tirofiban—Nausea—Anastrozole—breast cancer	0.000643	0.00208	CcSEcCtD
Tirofiban—Chills—Gemcitabine—breast cancer	0.000643	0.00208	CcSEcCtD
Tirofiban—Hypertension—Thiotepa—breast cancer	0.00064	0.00208	CcSEcCtD
Tirofiban—Haematuria—Paclitaxel—breast cancer	0.000637	0.00207	CcSEcCtD
Tirofiban—Anaphylactic shock—Vinorelbine—breast cancer	0.000634	0.00205	CcSEcCtD
Tirofiban—Pain—Tamoxifen—breast cancer	0.000633	0.00205	CcSEcCtD
Tirofiban—Thrombocytopenia—Vinorelbine—breast cancer	0.00062	0.00201	CcSEcCtD
Tirofiban—Pain—Melphalan—breast cancer	0.00062	0.00201	CcSEcCtD
Tirofiban—Hypersensitivity—Chlorambucil—breast cancer	0.000613	0.00199	CcSEcCtD
Tirofiban—Bradycardia—Paclitaxel—breast cancer	0.000611	0.00198	CcSEcCtD
Tirofiban—Nausea—Raloxifene—breast cancer	0.00061	0.00198	CcSEcCtD
Tirofiban—Nausea—Idarubicin—breast cancer	0.00061	0.00198	CcSEcCtD
Tirofiban—Pain—Goserelin—breast cancer	0.000605	0.00196	CcSEcCtD
Tirofiban—Haemoglobin—Paclitaxel—breast cancer	0.000603	0.00196	CcSEcCtD
Tirofiban—Haemorrhage—Paclitaxel—breast cancer	0.0006	0.00195	CcSEcCtD
Tirofiban—Thrombocytopenia—Thiotepa—breast cancer	0.000592	0.00192	CcSEcCtD
Tirofiban—Urticaria—Tamoxifen—breast cancer	0.000588	0.00191	CcSEcCtD
Tirofiban—Urticaria—Melphalan—breast cancer	0.000576	0.00187	CcSEcCtD
Tirofiban—Urticaria—Goserelin—breast cancer	0.000562	0.00182	CcSEcCtD
Tirofiban—Hypersensitivity—Vinblastine—breast cancer	0.000562	0.00182	CcSEcCtD
Tirofiban—Body temperature increased—Goserelin—breast cancer	0.000559	0.00181	CcSEcCtD
Tirofiban—Myocardial infarction—Docetaxel—breast cancer	0.000555	0.0018	CcSEcCtD
Tirofiban—Hypertension—Irinotecan—breast cancer	0.000553	0.00179	CcSEcCtD
Tirofiban—Hypertension—Mitoxantrone—breast cancer	0.000553	0.00179	CcSEcCtD
Tirofiban—Hypersensitivity—Tamoxifen—breast cancer	0.000546	0.00177	CcSEcCtD
Tirofiban—Pain—Vinorelbine—breast cancer	0.000542	0.00176	CcSEcCtD
Tirofiban—Hypertension—Gemcitabine—breast cancer	0.000538	0.00175	CcSEcCtD
Tirofiban—Chills—Paclitaxel—breast cancer	0.000538	0.00175	CcSEcCtD
Tirofiban—Myocardial infarction—Capecitabine—breast cancer	0.000538	0.00174	CcSEcCtD
Tirofiban—Hypersensitivity—Melphalan—breast cancer	0.000534	0.00173	CcSEcCtD
Tirofiban—Haematuria—Capecitabine—breast cancer	0.000523	0.0017	CcSEcCtD
Tirofiban—Oedema—Mitoxantrone—breast cancer	0.000523	0.00169	CcSEcCtD
Tirofiban—Oedema—Irinotecan—breast cancer	0.000523	0.00169	CcSEcCtD
Tirofiban—Anaphylactic shock—Irinotecan—breast cancer	0.000523	0.00169	CcSEcCtD
Tirofiban—Anaphylactic shock—Mitoxantrone—breast cancer	0.000523	0.00169	CcSEcCtD
Tirofiban—Hypersensitivity—Goserelin—breast cancer	0.000521	0.00169	CcSEcCtD
Tirofiban—Pain—Thiotepa—breast cancer	0.000517	0.00168	CcSEcCtD
Tirofiban—Thrombocytopenia—Mitoxantrone—breast cancer	0.000512	0.00166	CcSEcCtD
Tirofiban—Thrombocytopenia—Irinotecan—breast cancer	0.000512	0.00166	CcSEcCtD
Tirofiban—Haemoglobin—Docetaxel—breast cancer	0.000511	0.00166	CcSEcCtD
Tirofiban—Anaphylactic shock—Gemcitabine—breast cancer	0.000509	0.00165	CcSEcCtD
Tirofiban—Oedema—Gemcitabine—breast cancer	0.000509	0.00165	CcSEcCtD
Tirofiban—Haemorrhage—Docetaxel—breast cancer	0.000508	0.00165	CcSEcCtD
Tirofiban—Hyperhidrosis—Irinotecan—breast cancer	0.000505	0.00164	CcSEcCtD
Tirofiban—Hyperhidrosis—Mitoxantrone—breast cancer	0.000505	0.00164	CcSEcCtD
Tirofiban—Dizziness—Vinblastine—breast cancer	0.000504	0.00164	CcSEcCtD
Tirofiban—Urticaria—Vinorelbine—breast cancer	0.000503	0.00163	CcSEcCtD
Tirofiban—Bradycardia—Capecitabine—breast cancer	0.000501	0.00163	CcSEcCtD
Tirofiban—Body temperature increased—Vinorelbine—breast cancer	0.000501	0.00162	CcSEcCtD
Tirofiban—Anaphylactic shock—Fluorouracil—breast cancer	0.0005	0.00162	CcSEcCtD
Tirofiban—Oedema—Fluorouracil—breast cancer	0.0005	0.00162	CcSEcCtD
Tirofiban—Thrombocytopenia—Gemcitabine—breast cancer	0.000498	0.00162	CcSEcCtD
Tirofiban—Haemoglobin—Capecitabine—breast cancer	0.000495	0.0016	CcSEcCtD
Tirofiban—Nausea—Chlorambucil—breast cancer	0.000494	0.0016	CcSEcCtD
Tirofiban—Haemorrhage—Capecitabine—breast cancer	0.000492	0.0016	CcSEcCtD
Tirofiban—Hyperhidrosis—Gemcitabine—breast cancer	0.000492	0.0016	CcSEcCtD
Tirofiban—Thrombocytopenia—Fluorouracil—breast cancer	0.00049	0.00159	CcSEcCtD
Tirofiban—Dizziness—Tamoxifen—breast cancer	0.00049	0.00159	CcSEcCtD
Tirofiban—Urticaria—Thiotepa—breast cancer	0.000481	0.00156	CcSEcCtD
Tirofiban—Body temperature increased—Thiotepa—breast cancer	0.000478	0.00155	CcSEcCtD
Tirofiban—Headache—Vinblastine—breast cancer	0.000478	0.00155	CcSEcCtD
Tirofiban—Dizziness—Goserelin—breast cancer	0.000468	0.00152	CcSEcCtD
Tirofiban—Hypersensitivity—Vinorelbine—breast cancer	0.000467	0.00151	CcSEcCtD
Tirofiban—Headache—Tamoxifen—breast cancer	0.000464	0.0015	CcSEcCtD
Tirofiban—Chills—Docetaxel—breast cancer	0.000456	0.00148	CcSEcCtD
Tirofiban—Nausea—Vinblastine—breast cancer	0.000453	0.00147	CcSEcCtD
Tirofiban—Hypertension—Paclitaxel—breast cancer	0.000451	0.00146	CcSEcCtD
Tirofiban—Pain—Irinotecan—breast cancer	0.000447	0.00145	CcSEcCtD
Tirofiban—Pain—Mitoxantrone—breast cancer	0.000447	0.00145	CcSEcCtD
Tirofiban—Hypersensitivity—Thiotepa—breast cancer	0.000446	0.00145	CcSEcCtD
Tirofiban—Headache—Goserelin—breast cancer	0.000443	0.00144	CcSEcCtD
Tirofiban—Chills—Capecitabine—breast cancer	0.000442	0.00143	CcSEcCtD
Tirofiban—Nausea—Tamoxifen—breast cancer	0.00044	0.00143	CcSEcCtD
Tirofiban—Pain—Gemcitabine—breast cancer	0.000435	0.00141	CcSEcCtD
Tirofiban—Nausea—Melphalan—breast cancer	0.000431	0.0014	CcSEcCtD
Tirofiban—Pain—Fluorouracil—breast cancer	0.000428	0.00139	CcSEcCtD
Tirofiban—Oedema—Paclitaxel—breast cancer	0.000426	0.00138	CcSEcCtD
Tirofiban—Anaphylactic shock—Paclitaxel—breast cancer	0.000426	0.00138	CcSEcCtD
Tirofiban—Nausea—Goserelin—breast cancer	0.00042	0.00136	CcSEcCtD
Tirofiban—Dizziness—Vinorelbine—breast cancer	0.000419	0.00136	CcSEcCtD
Tirofiban—Thrombocytopenia—Paclitaxel—breast cancer	0.000417	0.00135	CcSEcCtD
Tirofiban—Urticaria—Mitoxantrone—breast cancer	0.000415	0.00135	CcSEcCtD
Tirofiban—Body temperature increased—Mitoxantrone—breast cancer	0.000413	0.00134	CcSEcCtD
Tirofiban—Body temperature increased—Irinotecan—breast cancer	0.000413	0.00134	CcSEcCtD
Tirofiban—Hyperhidrosis—Paclitaxel—breast cancer	0.000412	0.00134	CcSEcCtD
Tirofiban—Body temperature increased—Gemcitabine—breast cancer	0.000402	0.0013	CcSEcCtD
Tirofiban—Dizziness—Thiotepa—breast cancer	0.0004	0.0013	CcSEcCtD
Tirofiban—Urticaria—Fluorouracil—breast cancer	0.000398	0.00129	CcSEcCtD
Tirofiban—Headache—Vinorelbine—breast cancer	0.000397	0.00129	CcSEcCtD
Tirofiban—Body temperature increased—Fluorouracil—breast cancer	0.000396	0.00128	CcSEcCtD
Tirofiban—Sweating—Methotrexate—breast cancer	0.000391	0.00127	CcSEcCtD
Tirofiban—Haematuria—Methotrexate—breast cancer	0.000389	0.00126	CcSEcCtD
Tirofiban—Hypersensitivity—Mitoxantrone—breast cancer	0.000385	0.00125	CcSEcCtD
Tirofiban—Hypersensitivity—Irinotecan—breast cancer	0.000385	0.00125	CcSEcCtD
Tirofiban—Hypertension—Docetaxel—breast cancer	0.000382	0.00124	CcSEcCtD
Tirofiban—Headache—Thiotepa—breast cancer	0.000379	0.00123	CcSEcCtD
Tirofiban—Nausea—Vinorelbine—breast cancer	0.000376	0.00122	CcSEcCtD
Tirofiban—Hypertension—Capecitabine—breast cancer	0.00037	0.0012	CcSEcCtD
Tirofiban—Hypersensitivity—Fluorouracil—breast cancer	0.000369	0.0012	CcSEcCtD
Tirofiban—Haemoglobin—Methotrexate—breast cancer	0.000368	0.00119	CcSEcCtD
Tirofiban—Haemorrhage—Methotrexate—breast cancer	0.000366	0.00119	CcSEcCtD
Tirofiban—Sweating—Epirubicin—breast cancer	0.000366	0.00119	CcSEcCtD
Tirofiban—Pain—Paclitaxel—breast cancer	0.000364	0.00118	CcSEcCtD
Tirofiban—Haematuria—Epirubicin—breast cancer	0.000364	0.00118	CcSEcCtD
Tirofiban—Oedema—Docetaxel—breast cancer	0.000361	0.00117	CcSEcCtD
Tirofiban—Anaphylactic shock—Docetaxel—breast cancer	0.000361	0.00117	CcSEcCtD
Tirofiban—Nausea—Thiotepa—breast cancer	0.000359	0.00117	CcSEcCtD
Tirofiban—Thrombocytopenia—Docetaxel—breast cancer	0.000354	0.00115	CcSEcCtD
Tirofiban—Oedema—Capecitabine—breast cancer	0.00035	0.00113	CcSEcCtD
Tirofiban—Bradycardia—Epirubicin—breast cancer	0.000349	0.00113	CcSEcCtD
Tirofiban—Dizziness—Irinotecan—breast cancer	0.000346	0.00112	CcSEcCtD
Tirofiban—Haemoglobin—Epirubicin—breast cancer	0.000345	0.00112	CcSEcCtD
Tirofiban—Haemorrhage—Epirubicin—breast cancer	0.000343	0.00111	CcSEcCtD
Tirofiban—Thrombocytopenia—Capecitabine—breast cancer	0.000342	0.00111	CcSEcCtD
Tirofiban—Sweating—Doxorubicin—breast cancer	0.000339	0.0011	CcSEcCtD
Tirofiban—Urticaria—Paclitaxel—breast cancer	0.000339	0.0011	CcSEcCtD
Tirofiban—Hyperhidrosis—Capecitabine—breast cancer	0.000338	0.0011	CcSEcCtD
Tirofiban—Haematuria—Doxorubicin—breast cancer	0.000337	0.00109	CcSEcCtD
Tirofiban—Body temperature increased—Paclitaxel—breast cancer	0.000337	0.00109	CcSEcCtD
Tirofiban—Dizziness—Fluorouracil—breast cancer	0.000331	0.00107	CcSEcCtD
Tirofiban—Chills—Methotrexate—breast cancer	0.000329	0.00107	CcSEcCtD
Tirofiban—Headache—Mitoxantrone—breast cancer	0.000327	0.00106	CcSEcCtD
Tirofiban—Headache—Irinotecan—breast cancer	0.000327	0.00106	CcSEcCtD
Tirofiban—Bradycardia—Doxorubicin—breast cancer	0.000323	0.00105	CcSEcCtD
Tirofiban—Haemoglobin—Doxorubicin—breast cancer	0.000319	0.00103	CcSEcCtD
Tirofiban—Headache—Gemcitabine—breast cancer	0.000319	0.00103	CcSEcCtD
Tirofiban—Haemorrhage—Doxorubicin—breast cancer	0.000317	0.00103	CcSEcCtD
Tirofiban—Hypersensitivity—Paclitaxel—breast cancer	0.000314	0.00102	CcSEcCtD
Tirofiban—Headache—Fluorouracil—breast cancer	0.000314	0.00102	CcSEcCtD
Tirofiban—Nausea—Mitoxantrone—breast cancer	0.00031	0.00101	CcSEcCtD
Tirofiban—Nausea—Irinotecan—breast cancer	0.00031	0.00101	CcSEcCtD
Tirofiban—Pain—Docetaxel—breast cancer	0.000309	0.001	CcSEcCtD
Tirofiban—Chills—Epirubicin—breast cancer	0.000308	0.000998	CcSEcCtD
Tirofiban—Nausea—Gemcitabine—breast cancer	0.000302	0.000981	CcSEcCtD
Tirofiban—Pain—Capecitabine—breast cancer	0.000299	0.00097	CcSEcCtD
Tirofiban—Nausea—Fluorouracil—breast cancer	0.000297	0.000964	CcSEcCtD
Tirofiban—Body temperature increased—Docetaxel—breast cancer	0.000286	0.000926	CcSEcCtD
Tirofiban—Chills—Doxorubicin—breast cancer	0.000285	0.000923	CcSEcCtD
Tirofiban—Dizziness—Paclitaxel—breast cancer	0.000282	0.000914	CcSEcCtD
Tirofiban—Urticaria—Capecitabine—breast cancer	0.000278	0.000901	CcSEcCtD
Tirofiban—Body temperature increased—Capecitabine—breast cancer	0.000276	0.000897	CcSEcCtD
Tirofiban—Headache—Paclitaxel—breast cancer	0.000267	0.000866	CcSEcCtD
Tirofiban—Hypersensitivity—Docetaxel—breast cancer	0.000266	0.000863	CcSEcCtD
Tirofiban—Anaphylactic shock—Methotrexate—breast cancer	0.00026	0.000844	CcSEcCtD
Tirofiban—Hypertension—Epirubicin—breast cancer	0.000258	0.000836	CcSEcCtD
Tirofiban—Hypersensitivity—Capecitabine—breast cancer	0.000258	0.000836	CcSEcCtD
Tirofiban—Thrombocytopenia—Methotrexate—breast cancer	0.000255	0.000827	CcSEcCtD
Tirofiban—Nausea—Paclitaxel—breast cancer	0.000253	0.000821	CcSEcCtD
Tirofiban—Hyperhidrosis—Methotrexate—breast cancer	0.000252	0.000816	CcSEcCtD
Tirofiban—Oedema—Epirubicin—breast cancer	0.000244	0.00079	CcSEcCtD
Tirofiban—Anaphylactic shock—Epirubicin—breast cancer	0.000244	0.00079	CcSEcCtD
Tirofiban—Dizziness—Docetaxel—breast cancer	0.000239	0.000775	CcSEcCtD
Tirofiban—Thrombocytopenia—Epirubicin—breast cancer	0.000239	0.000774	CcSEcCtD
Tirofiban—Hypertension—Doxorubicin—breast cancer	0.000238	0.000773	CcSEcCtD
Tirofiban—Hyperhidrosis—Epirubicin—breast cancer	0.000236	0.000764	CcSEcCtD
Tirofiban—Dizziness—Capecitabine—breast cancer	0.000231	0.00075	CcSEcCtD
Tirofiban—Headache—Docetaxel—breast cancer	0.000226	0.000734	CcSEcCtD
Tirofiban—Anaphylactic shock—Doxorubicin—breast cancer	0.000225	0.000731	CcSEcCtD
Tirofiban—Oedema—Doxorubicin—breast cancer	0.000225	0.000731	CcSEcCtD
Tirofiban—Pain—Methotrexate—breast cancer	0.000223	0.000722	CcSEcCtD
Tirofiban—Thrombocytopenia—Doxorubicin—breast cancer	0.000221	0.000716	CcSEcCtD
Tirofiban—Headache—Capecitabine—breast cancer	0.000219	0.000711	CcSEcCtD
Tirofiban—Hyperhidrosis—Doxorubicin—breast cancer	0.000218	0.000707	CcSEcCtD
Tirofiban—Nausea—Docetaxel—breast cancer	0.000215	0.000696	CcSEcCtD
Tirofiban—Pain—Epirubicin—breast cancer	0.000208	0.000676	CcSEcCtD
Tirofiban—Nausea—Capecitabine—breast cancer	0.000208	0.000674	CcSEcCtD
Tirofiban—Urticaria—Methotrexate—breast cancer	0.000207	0.000671	CcSEcCtD
Tirofiban—Body temperature increased—Methotrexate—breast cancer	0.000206	0.000667	CcSEcCtD
Tirofiban—Urticaria—Epirubicin—breast cancer	0.000194	0.000628	CcSEcCtD
Tirofiban—Pain—Doxorubicin—breast cancer	0.000193	0.000625	CcSEcCtD
Tirofiban—Body temperature increased—Epirubicin—breast cancer	0.000193	0.000625	CcSEcCtD
Tirofiban—Hypersensitivity—Methotrexate—breast cancer	0.000192	0.000622	CcSEcCtD
Tirofiban—Hypersensitivity—Epirubicin—breast cancer	0.00018	0.000582	CcSEcCtD
Tirofiban—Urticaria—Doxorubicin—breast cancer	0.000179	0.000581	CcSEcCtD
Tirofiban—Body temperature increased—Doxorubicin—breast cancer	0.000178	0.000578	CcSEcCtD
Tirofiban—Dizziness—Methotrexate—breast cancer	0.000172	0.000558	CcSEcCtD
Tirofiban—Hypersensitivity—Doxorubicin—breast cancer	0.000166	0.000539	CcSEcCtD
Tirofiban—Headache—Methotrexate—breast cancer	0.000163	0.000529	CcSEcCtD
Tirofiban—Dizziness—Epirubicin—breast cancer	0.000161	0.000523	CcSEcCtD
Tirofiban—Nausea—Methotrexate—breast cancer	0.000155	0.000502	CcSEcCtD
Tirofiban—Headache—Epirubicin—breast cancer	0.000153	0.000495	CcSEcCtD
Tirofiban—Dizziness—Doxorubicin—breast cancer	0.000149	0.000483	CcSEcCtD
Tirofiban—Nausea—Epirubicin—breast cancer	0.000145	0.000469	CcSEcCtD
Tirofiban—Headache—Doxorubicin—breast cancer	0.000141	0.000458	CcSEcCtD
Tirofiban—Nausea—Doxorubicin—breast cancer	0.000134	0.000434	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—FLT1—breast cancer	7.76e-05	0.000146	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF3—breast cancer	7.72e-05	0.000145	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SQSTM1—breast cancer	7.72e-05	0.000145	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CNR2—breast cancer	7.72e-05	0.000145	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JAG1—breast cancer	7.62e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—SRC—breast cancer	7.61e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PARP1—breast cancer	7.59e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOTCH3—breast cancer	7.59e-05	0.000143	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—MAPK3—breast cancer	7.57e-05	0.000142	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—DKK1—breast cancer	7.53e-05	0.000142	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—HRAS—breast cancer	7.5e-05	0.000141	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CALCA—breast cancer	7.5e-05	0.000141	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RAF1—breast cancer	7.49e-05	0.000141	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFC—breast cancer	7.47e-05	0.000141	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SRC—breast cancer	7.46e-05	0.00014	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RELA—breast cancer	7.46e-05	0.00014	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ERBB2—breast cancer	7.41e-05	0.000139	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—breast cancer	7.41e-05	0.000139	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RPS6—breast cancer	7.41e-05	0.000139	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JAG2—breast cancer	7.36e-05	0.000139	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF4—breast cancer	7.35e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—RAF1—breast cancer	7.35e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—STAT3—breast cancer	7.34e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCR4—breast cancer	7.32e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL12—breast cancer	7.32e-05	0.000138	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—VEGFA—breast cancer	7.27e-05	0.000137	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—WNT1—breast cancer	7.25e-05	0.000137	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—EGFR—breast cancer	7.2e-05	0.000135	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PAK1—breast cancer	7.19e-05	0.000135	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—breast cancer	7.18e-05	0.000135	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CB—breast cancer	7.18e-05	0.000135	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TCF7L2—breast cancer	7.06e-05	0.000133	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MAPK3—breast cancer	7.01e-05	0.000132	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—AKT1—breast cancer	6.93e-05	0.00013	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—MAPK3—breast cancer	6.88e-05	0.000129	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOTCH4—breast cancer	6.88e-05	0.000129	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—GZMB—breast cancer	6.83e-05	0.000129	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HSP90AA1—breast cancer	6.81e-05	0.000128	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOTCH2—breast cancer	6.81e-05	0.000128	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TGFB1—breast cancer	6.8e-05	0.000128	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—KRAS—breast cancer	6.8e-05	0.000128	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB1—breast cancer	6.67e-05	0.000126	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EGFR—breast cancer	6.67e-05	0.000126	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL2—breast cancer	6.64e-05	0.000125	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AGTR2—breast cancer	6.64e-05	0.000125	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AGTR1—breast cancer	6.62e-05	0.000125	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PRL—breast cancer	6.62e-05	0.000125	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—IL2—breast cancer	6.59e-05	0.000124	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTHLH—breast cancer	6.56e-05	0.000123	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BMP2—breast cancer	6.56e-05	0.000123	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ADAM10—breast cancer	6.53e-05	0.000123	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STK11—breast cancer	6.53e-05	0.000123	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CTNNB1—breast cancer	6.49e-05	0.000122	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PLG—breast cancer	6.45e-05	0.000121	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP9—breast cancer	6.36e-05	0.00012	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EDNRB—breast cancer	6.35e-05	0.00012	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—breast cancer	6.35e-05	0.00012	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF10—breast cancer	6.35e-05	0.000119	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—KRAS—breast cancer	6.3e-05	0.000119	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PGR—breast cancer	6.29e-05	0.000118	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—THBS1—breast cancer	6.26e-05	0.000118	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—KRAS—breast cancer	6.18e-05	0.000116	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDGFA—breast cancer	6.13e-05	0.000115	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFBR2—breast cancer	6.04e-05	0.000114	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FLT1—breast cancer	5.97e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SQSTM1—breast cancer	5.95e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF3—breast cancer	5.95e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ITPR1—breast cancer	5.94e-05	0.000112	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP3—breast cancer	5.9e-05	0.000111	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB4—breast cancer	5.9e-05	0.000111	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT5A—breast cancer	5.9e-05	0.000111	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JAG1—breast cancer	5.87e-05	0.00011	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—SRC—breast cancer	5.86e-05	0.00011	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PARP1—breast cancer	5.85e-05	0.00011	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOTCH3—breast cancer	5.85e-05	0.00011	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—HRAS—breast cancer	5.78e-05	0.000109	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CALCA—breast cancer	5.78e-05	0.000109	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SRC—breast cancer	5.75e-05	0.000108	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SMAD4—breast cancer	5.72e-05	0.000108	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—breast cancer	5.71e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RPS6—breast cancer	5.71e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1R—breast cancer	5.68e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PIK3CA—breast cancer	5.68e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF4—breast cancer	5.66e-05	0.000107	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—STAT3—breast cancer	5.65e-05	0.000106	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL12—breast cancer	5.64e-05	0.000106	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCR4—breast cancer	5.64e-05	0.000106	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—breast cancer	5.6e-05	0.000105	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HES1—breast cancer	5.58e-05	0.000105	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PLA2G4A—breast cancer	5.55e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NCOR1—breast cancer	5.55e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PAK1—breast cancer	5.54e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—breast cancer	5.53e-05	0.000104	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—breast cancer	5.49e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CSF2—breast cancer	5.49e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGF1—breast cancer	5.49e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NRG1—breast cancer	5.45e-05	0.000103	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TCF7L2—breast cancer	5.44e-05	0.000102	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—H2AFX—breast cancer	5.41e-05	0.000102	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MAPK3—breast cancer	5.4e-05	0.000102	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—E2F1—breast cancer	5.37e-05	0.000101	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—HRAS—breast cancer	5.36e-05	0.000101	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MAPK3—breast cancer	5.3e-05	9.97e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—HRAS—breast cancer	5.25e-05	9.89e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOTCH2—breast cancer	5.24e-05	9.87e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HSP90AA1—breast cancer	5.24e-05	9.87e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TGFB1—breast cancer	5.24e-05	9.86e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SPP1—breast cancer	5.16e-05	9.71e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB1—breast cancer	5.14e-05	9.67e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EGFR—breast cancer	5.14e-05	9.67e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—breast cancer	5.13e-05	9.65e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB3—breast cancer	5.1e-05	9.6e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PRL—breast cancer	5.1e-05	9.6e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AGTR1—breast cancer	5.1e-05	9.6e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGFR2—breast cancer	5.1e-05	9.59e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STK11—breast cancer	5.03e-05	9.46e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ADAM10—breast cancer	5.03e-05	9.46e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PLG—breast cancer	4.97e-05	9.36e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—breast cancer	4.89e-05	9.21e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TERT—breast cancer	4.89e-05	9.2e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF10—breast cancer	4.89e-05	9.2e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—KRAS—breast cancer	4.85e-05	9.13e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—KRAS—breast cancer	4.76e-05	8.96e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FGFR1—breast cancer	4.75e-05	8.94e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—AKT1—breast cancer	4.73e-05	8.9e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDGFA—breast cancer	4.72e-05	8.88e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HIF1A—breast cancer	4.68e-05	8.8e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFBR2—breast cancer	4.65e-05	8.76e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—AKT1—breast cancer	4.64e-05	8.73e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ITPR1—breast cancer	4.58e-05	8.61e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LEP—breast cancer	4.57e-05	8.59e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB4—breast cancer	4.55e-05	8.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT5A—breast cancer	4.55e-05	8.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP3—breast cancer	4.55e-05	8.56e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CAV1—breast cancer	4.52e-05	8.51e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KDR—breast cancer	4.47e-05	8.42e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SMAD4—breast cancer	4.4e-05	8.29e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1R—breast cancer	4.38e-05	8.24e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PIK3CA—breast cancer	4.37e-05	8.23e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ESR1—breast cancer	4.36e-05	8.2e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—FN1—breast cancer	4.31e-05	8.1e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HES1—breast cancer	4.3e-05	8.09e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NCOR1—breast cancer	4.28e-05	8.05e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PLA2G4A—breast cancer	4.28e-05	8.05e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NFKBIA—breast cancer	4.26e-05	8.01e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—breast cancer	4.23e-05	7.96e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CSF2—breast cancer	4.23e-05	7.96e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGF1—breast cancer	4.23e-05	7.96e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOTCH1—breast cancer	4.21e-05	7.93e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NRG1—breast cancer	4.2e-05	7.9e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—H2AFX—breast cancer	4.17e-05	7.84e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—E2F1—breast cancer	4.14e-05	7.79e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—HRAS—breast cancer	4.13e-05	7.76e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KIT—breast cancer	4.12e-05	7.76e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CG—breast cancer	4.12e-05	7.76e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—APC—breast cancer	4.12e-05	7.76e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGF—breast cancer	4.07e-05	7.67e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HRAS—breast cancer	4.05e-05	7.62e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SPP1—breast cancer	3.97e-05	7.48e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—breast cancer	3.95e-05	7.43e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB3—breast cancer	3.93e-05	7.4e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGFR2—breast cancer	3.93e-05	7.39e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—BRAF—breast cancer	3.87e-05	7.29e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IGF1—breast cancer	3.77e-05	7.1e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT2—breast cancer	3.77e-05	7.1e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TERT—breast cancer	3.77e-05	7.09e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FGFR1—breast cancer	3.66e-05	6.88e-05	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—AKT1—breast cancer	3.64e-05	6.85e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CD—breast cancer	3.62e-05	6.82e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HIF1A—breast cancer	3.6e-05	6.78e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SERPINE1—breast cancer	3.58e-05	6.74e-05	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—AKT1—breast cancer	3.57e-05	6.72e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LEP—breast cancer	3.52e-05	6.62e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CAV1—breast cancer	3.49e-05	6.56e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KDR—breast cancer	3.45e-05	6.49e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOS3—breast cancer	3.42e-05	6.44e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ESR1—breast cancer	3.36e-05	6.32e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—FN1—breast cancer	3.32e-05	6.24e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NFKBIA—breast cancer	3.28e-05	6.17e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOTCH1—breast cancer	3.25e-05	6.11e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MDM2—breast cancer	3.25e-05	6.11e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RAF1—breast cancer	3.23e-05	6.09e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RELA—breast cancer	3.22e-05	6.06e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB2—breast cancer	3.2e-05	6.02e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CG—breast cancer	3.17e-05	5.97e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KIT—breast cancer	3.17e-05	5.97e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—APC—breast cancer	3.17e-05	5.97e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MTOR—breast cancer	3.16e-05	5.94e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CB—breast cancer	3.16e-05	5.94e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGF—breast cancer	3.14e-05	5.91e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL8—breast cancer	3.03e-05	5.71e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—BRAF—breast cancer	2.98e-05	5.62e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1B—breast cancer	2.96e-05	5.58e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IGF1—breast cancer	2.91e-05	5.47e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT2—breast cancer	2.9e-05	5.47e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CASP3—breast cancer	2.9e-05	5.47e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL2—breast cancer	2.9e-05	5.46e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CCND1—breast cancer	2.83e-05	5.32e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—JUN—breast cancer	2.82e-05	5.31e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CTNNB1—breast cancer	2.8e-05	5.27e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CD—breast cancer	2.79e-05	5.25e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SERPINE1—breast cancer	2.76e-05	5.19e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—breast cancer	2.74e-05	5.17e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CDKN1A—breast cancer	2.74e-05	5.15e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PTEN—breast cancer	2.73e-05	5.13e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK8—breast cancer	2.67e-05	5.02e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOS3—breast cancer	2.64e-05	4.96e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SRC—breast cancer	2.53e-05	4.76e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MDM2—breast cancer	2.5e-05	4.7e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RAF1—breast cancer	2.49e-05	4.69e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RELA—breast cancer	2.48e-05	4.67e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB2—breast cancer	2.47e-05	4.64e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—breast cancer	2.46e-05	4.64e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—STAT3—breast cancer	2.44e-05	4.59e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MTOR—breast cancer	2.43e-05	4.58e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CB—breast cancer	2.43e-05	4.58e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL8—breast cancer	2.34e-05	4.4e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MAPK3—breast cancer	2.33e-05	4.39e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1B—breast cancer	2.28e-05	4.3e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MYC—breast cancer	2.27e-05	4.27e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFB1—breast cancer	2.26e-05	4.26e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CASP3—breast cancer	2.24e-05	4.21e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL2—breast cancer	2.23e-05	4.2e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGFR—breast cancer	2.22e-05	4.17e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CCND1—breast cancer	2.18e-05	4.1e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—JUN—breast cancer	2.17e-05	4.09e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CTNNB1—breast cancer	2.16e-05	4.06e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—breast cancer	2.11e-05	3.98e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CDKN1A—breast cancer	2.11e-05	3.96e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PTEN—breast cancer	2.1e-05	3.96e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KRAS—breast cancer	2.1e-05	3.94e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK8—breast cancer	2.06e-05	3.87e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SRC—breast cancer	1.95e-05	3.67e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PIK3CA—breast cancer	1.93e-05	3.62e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—breast cancer	1.9e-05	3.57e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—STAT3—breast cancer	1.88e-05	3.54e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—breast cancer	1.86e-05	3.5e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MAPK3—breast cancer	1.8e-05	3.38e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HRAS—breast cancer	1.78e-05	3.35e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MYC—breast cancer	1.75e-05	3.29e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFB1—breast cancer	1.74e-05	3.28e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGFR—breast cancer	1.71e-05	3.22e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—breast cancer	1.7e-05	3.21e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KRAS—breast cancer	1.61e-05	3.04e-05	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AKT1—breast cancer	1.57e-05	2.96e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PIK3CA—breast cancer	1.48e-05	2.79e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—breast cancer	1.43e-05	2.7e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HRAS—breast cancer	1.37e-05	2.58e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—breast cancer	1.31e-05	2.47e-05	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AKT1—breast cancer	1.21e-05	2.28e-05	CbGpPWpGaD
